Logos Capital

Logos Capital is a San Francisco-based investment firm that backs biotechnology companies, applying scientific research and clinical analysis to investment decisions in transformative therapeutics. The firm's stated approach is disciplined and data-driven, with an emphasis on first-in-class and best-in-class innovations and on underwriting that covers both clinical and commercial outcomes. Its objective is stated as improving patient care, access, life expectancy and standards of care while generating long-term returns for investors.

Central to the firm's process is Logos Analytics, a proprietary data science platform used to model and analyse clinical data, evaluate clinical trial design, replicate statistical analyses and estimate the probability of clinical success. In practice, the firm describes continuous event tracking and proactive risk management as core to how positions are underwritten and monitored.

The team is multidisciplinary, with expertise spanning biotechnology, medicine, chemistry, engineering, biology and data science. Technical work at the firm draws on clinical data modelling, statistical analysis and probability-of-clinical-success modelling, applied across the biotechnology, healthcare, therapeutics and pharmaceuticals sectors. The firm is based in San Francisco, USA.